How is the Apogee Therapeutics Inc. today?

The Apogee Therapeutics Inc. today is trading in the green, up by 1.28% at 37.11.

How has Apogee Therapeutics Inc. performed historically?

The Apogee Therapeutics Inc. is currently trading up 1.28% on an intraday basis in the past week the index fell -6.00%. The index has been up 18.03% in the past quarter and fell -18.69% in the past year. You can view this in the overview section.

What is Apogee Therapeutics Inc. Annual Net Profit?

Apogee Therapeutics Inc. Annual Net Profit fell 116.88% in the last year to $182.15 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Apogee Therapeutics Inc. Price to Earning Ratio?

Apogee Therapeutics Inc. Price to Earning Ratio is -10.54, which is negative.

What is Apogee Therapeutics Inc. Stock Price?

Apogee Therapeutics Inc. Stock Price fell 18.69% and underperformed its sector by 64.41% in the past year.

What is Apogee Therapeutics Inc. Quarterly Net profit?

Apogee Therapeutics Inc. Quarterly Net profit fell 72.43% YoY to $55.34 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Apogee Therapeutics Inc. Debt to Equity Ratio?

Apogee Therapeutics Inc. Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Apogee Therapeutics Inc. Return on Equity(ROE)?

Apogee Therapeutics Inc. Return on Equity(ROE) for the last financial year was -33.22%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Apogee Therapeutics Inc. Mutual Fund Holding?

Apogee Therapeutics Inc. Mutual Fund Holding increased by 1.93% in the last quarter to 49.84.

What is Apogee Therapeutics Inc. Institutional Holding?

Apogee Therapeutics Inc. Institutional Holding increased by 6.75% in the last quarter to 107.3.

Apogee Therapeutics Inc. XNAS: APGE

Apogee Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Apogee Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Apogee Therapeutics Inc.
Rating: 1.15066675
Author: Trendlyne DVM scores

about

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with h...

37.11 0.47 (1.28%)

41.56% Fall from 52W High

232.3K XNAS Volume

XNAS 02 Jun, 2025 11:51 AM (EDT)

Board Meeting

The next board meeting for Apogee Therapeutics Inc. is on 05 Jun 2025 for the purpose of Apogee Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

39.9 / 100

No estimates available

Apogee Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apogee Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with h...

41.56% Fall from 52W High

SWOT Analysis

Apogee Therapeutics Inc. Live Price Chart

Apogee Therapeutics Inc. FAQ

How is Apogee Therapeutics Inc. today?

Apogee Therapeutics Inc. today is trading in the green, and is up by 1.28% at 37.11.

How has Apogee Therapeutics Inc. performed historically?

Apogee Therapeutics Inc. is currently trading up 1.28% on an intraday basis. In the past week the stock fell -6.00%. stock has been up 18.03% in the past quarter and fell -18.69% in the past year. You can view this in the overview section.